Clinical trial
Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic…
NCT00311168 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00311168 |
|---|---|
| Title | Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP) |
| Official title | Reduce Ventricular Pacing Using Ventricular Intrinsic Preference: VIP™ Study |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Bradycardia |
| Intervention type | Device |
| Interventions | Intervention/treatment |
| Enrollment | 135 |
| Start date | Feb 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Apr 5, 2006 |
| Last update posted | Aug 12, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: